A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of a Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine (Tdap, Boostrix) and Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine (Gardasil) in Healthy Adolescents When Administered With MenACWY Conjugate Vaccine [Studio Clinico di fase IV, Randomizzato, controllato con Placebo per valutare la Immunogenicita' e la Sicurezza della vaccino combinato contro Tetano, Tossoide Difterico Ridotto e Pertosse Acellulare (Tdap, Boostrix) e il vaccino Ricombinante Umano, Quadrivalente Papillomavirus [Tipo 6, 11, 16, 18] (Gardasil), in adolescenti sani quando somministrato con il Vaccino Coniugato MenACWY].

Trial Profile

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of a Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine (Tdap, Boostrix) and Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine (Gardasil) in Healthy Adolescents When Administered With MenACWY Conjugate Vaccine [Studio Clinico di fase IV, Randomizzato, controllato con Placebo per valutare la Immunogenicita' e la Sicurezza della vaccino combinato contro Tetano, Tossoide Difterico Ridotto e Pertosse Acellulare (Tdap, Boostrix) e il vaccino Ricombinante Umano, Quadrivalente Papillomavirus [Tipo 6, 11, 16, 18] (Gardasil), in adolescenti sani quando somministrato con il Vaccino Coniugato MenACWY].

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Apr 2014

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; DTaP vaccine; Human papillomavirus vaccine recombinant quadrivalent Merck
  • Indications Cervical cancer; Diphtheria; Human papillomavirus infections; Meningococcal infections; Pertussis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Nov 2012 Planned End Date changed from 1 Oct 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 04 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top